Bacteriophages (‘phages’ for short) are viruses that prey on bacteria.
 
Phages are the most ubiquitous organisms on Earth, and they abound in natural as well as in man-made environments, where ever bacteria exist.
 
GangaGen’s phage expertise and core bacteriophage technology is deployed towards developing safe and effective antibacterial products based on naturally-occurring bacteriophages. 

GangaGen has developed methods to rapidly isolate phages effective on a given species of bacteria.
Gangagen has developed methods to characterise phages and build effective custom cocktails against different pathogenic bacteria.

Additionally, GangaGen’s expertise allows making phage preparations fit for therapeutic application, with fully developed, scalable processes for production and purification, and analytical methods for quality control of bacteriophage lots.

GBPL is equipped with a library of ~500 phages and 3000 bacterial strains belonging to various genera, which is updated periodically. 